| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 10/21/2026 | ±1.7% | +0.7% | over-priced |
| 07/22/2026 | ±2.3% | +0.1% | over-priced |
| 04/22/2026 | ±1.8% | -0.4% | over-priced |
| 02/12/2026 | ±2.0% | -1.6% | over-priced |
| 10/16/2025 | ±2.0% | -0.7% | over-priced |
| 07/23/2025 | ±2.8% | -0.7% | over-priced |
| 04/16/2025 | ±4.2% | -2.0% | over-priced |
| 02/27/2025 | ±1.7% | +0.1% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q3 FY2026 | $0.57 | $4.0B | $1.1B |
| Q2 FY2026 | $0.54 | $3.9B | $1.0B |
| Q1 FY2026 | $0.43 | $3.5B | $807M |
| Q4 FY2025 | — | $3.5B | $720M |
CSX (CSX) reports in 86 days, with the next report estimated for 01/21/2027. Across the last 8 reports, options priced an average ±2.3% earnings move while the stock actually moved 0.8% on average — the market has systematically over-priced CSX's earnings risk. Fundamentals into the print: EPS up 54.1% year-over-year, revenue up 12.0%. QuantLogix's live 5-factor engine currently reads CSX as a neutral at 54/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →